Neuromuscular Blockade in ARDS
The use of neuromuscular blockade in acute respiratory distress syndrome (ARDS) is controversial. Renewed interest since the French ACURASYS trial in 2010
ACURASYS
The use of neuromuscular blockade in acute respiratory distress syndrome (ARDS) is controversial. Renewed interest since the French ACURASYS trial in 2010